The Global Epidemiology and Disease Burden of Cannabis Use and Dependence

[1]  L. Iversen.  The Science of Marijuana , 2018, Oxford Scholarship Online.

[2]  Abraham D. Flaxman,et al.  The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study , 2013, PloS one.

[3]  M. Auriacombe,et al.  WITHDRAWN: Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. , 2013, The Cochrane database of systematic reviews.

[4]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[5]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[6]  Alan D. Lopez,et al.  Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[7]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[8]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[9]  T. Vos,et al.  Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study , 2012, Population Health Metrics.

[10]  Wayne Hall,et al.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.

[11]  L. Degenhardt,et al.  What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. , 2011, Drug and alcohol dependence.

[12]  M. Large,et al.  Cannabis use and earlier onset of psychosis: a systematic meta-analysis. , 2011, Archives of general psychiatry.

[13]  J. Salomon.  New disability weights for the global burden of disease. , 2010, Bulletin of the World Health Organization.

[14]  T. Vos,et al.  Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. , 2010, Addictive behaviors.

[15]  R. Kotov,et al.  Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. , 2010, The American journal of psychiatry.

[16]  Wayne Hall,et al.  Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. , 2010, Drug and alcohol review.

[17]  Wayne Hall,et al.  Adverse health effects of non-medical cannabis use , 2009, The Lancet.

[18]  T. Vos,et al.  Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis? , 2009, PLoS medicine.

[19]  B. Soares,et al.  Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. , 2015, The Cochrane database of systematic reviews.

[20]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[21]  L. Degenhardt,et al.  Prevalence and correlates of cannabis use in developed and developing countries , 2007, Current opinion in psychiatry.

[22]  David Kavanagh,et al.  Cannabis use and misuse prevalence among people with psychosis. , 2005, The British journal of psychiatry : the journal of mental science.

[23]  J. McGrath,et al.  A Systematic Review of the Prevalence of Schizophrenia , 2005, PLoS medicine.

[24]  W. Hall,et al.  Epidemiology of cannabis use and its consequences , 1999 .

[25]  R. Seth,et al.  Chemistry and pharmacology of cannabis. , 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[26]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .